Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q1 2014 (← Previous) (Next →)

Filing Date: Nov 14, 2014

Total Value: $823M

Holdings (9)

VTI VANGUARD INDEX FDS 35.3%

Value $290M Shares 2,979,100 Est. Cost $57.39 Unrealized —

— OPHTHOTECH CORP 29.9%

Value $246M Shares 6,910,489 Est. Cost $32.35 Unrealized —

VGK VANGUARD INTL EQUITY INDEX F 15.3%

Value $126M Shares 2,101,000 Est. Cost $45.01 Unrealized —

INGN INOGEN INC 10.9%

Value $89.47M Shares 5,419,449 Est. Cost $17.78 Unrealized 0.0%

— FLEXION THERAPEUTICS 3.6%

Value $29.33M Shares 1,783,131 Est. Cost $16.45 Unrealized —

— WRIGHT MED GROUP INC 2.2%

Value $18.2M Shares 585,759 Est. Cost $23.81 Unrealized —

— TETRAPHASE PHARMACEUTICALS INC 1.2%

Value $9.801M Shares 900,000 Est. Cost $13.52 Unrealized —

— TETRAPHASE PHARMACEUTICALS INC 1.2%

Value $9.801M Shares 900,000 Est. Cost $13.52 Unrealized —

— WRIGHT MED GROUP INC 0.5%

Value $3.918M Shares 4,720,065 Est. Cost $2.50 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
VTI	VANGUARD INDEX FDS	2,979,100	$290M	35.3%	$57.39	—	—	922908769
—	OPHTHOTECH CORP	6,910,489	$246M	29.9%	$32.35	—	—	683745103
VGK	VANGUARD INTL EQUITY INDEX F	2,101,000	$126M	15.3%	$45.01	—	—	922042874
INGN	INOGEN INC	5,419,449	$89.47M	10.9%	$17.78	0.0%	—	45780L104
—	FLEXION THERAPEUTICS	1,783,131	$29.33M	3.6%	$16.45	—	—	33938J106
—	WRIGHT MED GROUP INC	585,759	$18.2M	2.2%	$23.81	—	—	98235T107
—	TETRAPHASE PHARMACEUTICALS INC	900,000	$9.801M	1.2%	$13.52	—	—	88164N105
—	TETRAPHASE PHARMACEUTICALS INC	900,000	$9.801M	1.2%	$13.52	—	—	88165N105
—	WRIGHT MED GROUP INC	4,720,065	$3.918M	0.5%	$2.50	—	—	98235T115